Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 06, 2026
Kraft Heinz (KHC) Stock Holds Near $25–$26 with +1.7% Gain as Q2 Beat Meets Impairment Charge

Kraft Heinz (KHC) Stock Holds Near $25–$26 with +1.7% Gain as Q2 Beat Meets Impairment Charge

Key Takeaways

  • Kraft Heinz shares have moved modestly — approximately +1.7% over the last 30 days — as the market digests a Q2 2026 earnings beat alongside a $7.4 billion non-cash impairment charge.
  • The company raised its full-year organic sales outlook to a decline of 0.5% to 2.0%, an improvement from its prior forecast of a 1.5% to 3.5% decline.
  • Market share losses narrowed significantly to 30 basis points in the first half of 2026, down from 90 basis points at the start of 2025, signaling early traction from the turnaround strategy.
  • Management is committing approximately $700 million in incremental brand investments for 2026, framing it as a margin trough year ahead of an expected recovery in 2027.
  • Analyst consensus remains cautious — rated "Reduce" with an average price target around $23, though the stock continues to offer a roughly 6.2% dividend yield.

Market Snapshot: KHC's Recent Performance

The Kraft Heinz Company (KHC) has traded in a relatively narrow range over the past month, with the stock hovering near the $25–$26 level. The muted price action reflects a tug-of-war between encouraging operational signals and persistent structural headwinds. On one hand, the company delivered a Q2 earnings beat on August 5, with adjusted EPS of $0.56 topping the $0.53 consensus and revenue of $6.26 billion exceeding estimates. On the other, a $7.4 billion non-cash impairment charge pushed reported results into a net loss, and organic sales still declined 1.3% year-over-year. Broader packaged-food sector challenges — including soft consumer demand, private-label competition, and elevated input costs — continue to weigh on sentiment. Within the consumer staples space, Kraft Heinz has modestly outperformed the S&P 500 over the trailing month, supported by its attractive dividend yield and improving market share trends. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Kraft Heinz Business Overview and Competitive Position

Kraft Heinz is one of the world's largest food and beverage companies, formed through the 2015 merger of Kraft Foods Group and H.J. Heinz Company. Its portfolio spans iconic brands including Heinz ketchup and condiments, Kraft Mac & Cheese, Oscar Mayer meats, Philadelphia cream cheese, Capri Sun, Lunchables, and Maxwell House coffee. The company operates across three recently reorganized geographic segments — North America, Europe and Pacific Developed Markets, and Emerging Markets — following a structural overhaul that took effect in July 2026. With a market capitalization of approximately $30.5 billion and annual revenues exceeding $24 billion, Kraft Heinz occupies a formidable position in global packaged foods. Investors track the stock closely for its defensive characteristics, high dividend yield, and ongoing turnaround narrative under CEO Steve Cahillane, who has emphasized brand reinvestment, innovation, and market share recovery as core strategic pillars.

Recent Developments Driving KHC

The most consequential event of the past month was Kraft Heinz's Q2 2026 earnings report on August 5. The company beat Wall Street expectations on both revenue and earnings, yet shares declined roughly 3.4% on the day as investors focused on the $7.4 billion impairment charge and an 18.4% drop in constant-currency adjusted operating income. The impairment reflects a write-down of brand-related intangible assets and signals management's willingness to reset the balance sheet while investing aggressively in the business.

Encouragingly, CEO Steve Cahillane pointed to "green shoots" across the portfolio. The percentage of company revenue gaining or holding market share climbed to 36% in the first half of 2026, up from just 21% for full-year 2025. Within the priority "WIN BIG" portfolio — which includes brands like Heinz, Philadelphia, and Capri Sun — 45% of revenue was gaining or holding share. Emerging Markets delivered 8.5% organic growth, with the Heinz brand up roughly 12% in those regions. The Global Away From Home business also returned to growth. From what I see, these share trends are worth monitoring closely.

On the innovation front, the company launched Power Mac & Cheese, a protein-enriched product that achieved first-quartile consumption metrics and secured distribution in approximately 35,000 stores. Additionally, a landmark alliance with Disney was announced in July, bringing Kraft Heinz-branded menu offerings to North American parks, resorts, and cruises. Meanwhile, UBS raised its price target on KHC from $24 to $25 in mid-July, and the company declared its regular quarterly dividend of $0.40 per share, maintaining one of the sector's highest yields. I reviewed the broader sector context with Tickeron’s AI Daily Buy/Sell Signals as part of my routine checks.

2026 Outlook and What Investors Should Watch

Kraft Heinz management has framed 2026 as an investment year — a margin trough — with the expectation that elevated brand spending will lay the foundation for a return to top-line growth in 2027. The company's updated full-year guidance calls for adjusted EPS of $2.03 to $2.09 and an organic sales decline of 0.5% to 2.0%. Investors should monitor several key factors through the remainder of 2026: whether the improving market share trajectory translates into sustained volume growth rather than narrower declines; the rollout and consumer reception of new product innovations, including Power Mac & Cheese and refreshed Oscar Mayer packaging; the impact of SNAP benefit reductions, which management estimates as a roughly 100-basis-point headwind; and the company's ability to manage projected 4% to 5% inflation in 2027 through productivity initiatives. On the macro front, private-label competition remains a concern, particularly as retailers continue investing in their own brands. The Disney partnership and the new regional operating structure may also become meaningful catalysts if they demonstrate measurable commercial traction in the coming quarters. With the stock trading below most analysts' fair-value estimates and carrying a 6.2% dividend yield, the balance of risk and reward hinges on execution of the turnaround plan.

AI Trading Bots for Portfolio Exposure

In my regular research process, I often review Tickeron’s Trending AI Robots to identify algorithmic strategies that align with names like KHC. The platform surfaces top-performing bots with transparent metrics on performance, trade history, and risk parameters across various styles, from swing trading to trend following. This helps me compare automated approaches without replacing my own fundamental analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: KHC

Aroon Indicator for KHC shows an upward move is likely

KHC's Aroon Indicator triggered a bullish signal on August 05, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 174 similar instances where the Aroon Indicator showed a similar pattern. In of the 174 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KHC advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for KHC moved out of overbought territory on July 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where KHC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KHC as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KHC turned negative on August 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KHC broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.847) is normal, around the industry mean (5.008). P/E Ratio (13.041) is within average values for comparable stocks, (36.312). Projected Growth (PEG Ratio) (0.993) is also within normal values, averaging (2.951). Dividend Yield (0.062) settles around the average of (0.055) among similar stocks. P/S Ratio (1.224) is also within normal values, averaging (8.087).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. KHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are Kraft Heinz Company (The) (NASDAQ:KHC), General Mills (NYSE:GIS), The Campbell's Company (NASDAQ:CPB), Beyond Meat (NASDAQ:BYND).

Industry description

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

Market Cap

The average market capitalization across the Food: Major Diversified Industry is 3.26B. The market cap for tickers in the group ranges from 68.52K to 255.67B. NSRGY holds the highest valuation in this group at 255.67B. The lowest valued company is THRC at 68.52K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Major Diversified Industry was -0%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -10%. FRPT experienced the highest price growth at 15%, while NCRA experienced the biggest fall at -41%.

Volume

The average weekly volume growth across all stocks in the Food: Major Diversified Industry was -35%. For the same stocks of the Industry, the average monthly volume growth was -19% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 64
Price Growth Rating: 60
SMR Rating: 79
Profit Risk Rating: 90
Seasonality Score: -14 (-100 ... +100)
View a ticker or compare two or three
KHC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of packaged food products

Industry FoodMajorDiversified

Profile
Details
Industry
Food Major Diversified
Address
One PPG Place
Phone
+1 412 456-5700
Employees
35000
Web
https://www.kraftheinzcompany.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.